Unknown

Dataset Information

0

Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis.


ABSTRACT: Activated B cells can regulate immunity and have been envisaged as a potential cell-based therapy for treating autoimmune diseases. However, activated human B cells can also propagate immune responses, and the effects resulting from their infusion into patients cannot be predicted. This led us to consider resting B cells, which in contrast are poorly immunogenic, as an alternative cellular platform for the suppression of unwanted immunity. Here, we report that resting B cells can be directly engineered with lentiviral vectors to express antigens in a remarkably simple, rapid, and effective way. Notably, this neither required nor induced activation of the B cells. With this approach we were able to produce reprogrammed resting B cells that inhibited antigen-specific CD4(+) T cells, CD8(+) T cells, and B cells upon adoptive transfer in mice. Furthermore, resting B cells engineered to ectopically express myelin oligodendrocyte glycoprotein antigen protected recipient mice from severe disability and demyelination in EAE, and even induced complete remission from disease in mice lacking functional natural Tregs, which otherwise developed chronic paralysis. In conclusion, our study introduces reprogrammed quiescent B cells as a novel tool for suppressing undesirable immunity.

SUBMITTER: Calderon-Gomez E 

PROVIDER: S-EPMC3431508 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis.

Calderón-Gómez Elisabeth E   Lampropoulou Vicky V   Shen Ping P   Neves Patricia P   Roch Toralf T   Stervbo Ulrik U   Rutz Sascha S   Kühl Anja A AA   Heppner Frank L FL   Loddenkemper Christoph C   Anderton Stephen M SM   Kanellopoulos Jean M JM   Charneau Pierre P   Fillatreau Simon S  

European journal of immunology 20110525 6


Activated B cells can regulate immunity and have been envisaged as a potential cell-based therapy for treating autoimmune diseases. However, activated human B cells can also propagate immune responses, and the effects resulting from their infusion into patients cannot be predicted. This led us to consider resting B cells, which in contrast are poorly immunogenic, as an alternative cellular platform for the suppression of unwanted immunity. Here, we report that resting B cells can be directly eng  ...[more]

Similar Datasets

| S-EPMC8126707 | biostudies-literature
| S-EPMC9128388 | biostudies-literature
2021-04-30 | GSE130177 | GEO
| S-EPMC5840162 | biostudies-literature
| S-EPMC9208101 | biostudies-literature
2024-10-25 | GSE228259 | GEO
| S-EPMC8954986 | biostudies-literature
| S-EPMC2577303 | biostudies-literature
| S-EPMC9540342 | biostudies-literature
2024-09-30 | GSE234291 | GEO